Peer Review History
| Original SubmissionJune 4, 2025 |
|---|
|
Dear Dr. Martin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 20 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Stefano Amatori, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and in Supporting Information files. Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 3. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly Reviewer #3: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: No Reviewer #3: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #1: Line 28: the years 2018-2023 are not the same as reported in the method section Lines 71-73: you mention ‘numerous alternative equations’, you need to cite them year, preferably with the name of the equation and/or the author Lines 88-89: add references for the mentioned studies/formulae Lines 110-112: add a reference Line 136: the years 2019-2024 are different to the years in the abstract Discussion: state in the beginning of the discussion whether you can confirm your hypothesis or not Reviewer #2: This manuscript, titled "Accuracy of Age-Based Maximal Heart Rate Equations in Adults with High and Low Cardiorespiratory Fitness Levels," aims to evaluate the predictive accuracy of seven common age-based MHR equations across different fitness levels. The study addresses an important and clinically relevant question. However, despite its clear structure and thorough data presentation, the work suffers from significant methodological limitations, inconsistent terminology, and analytical choices that reduce its scientific robustness. Below, I outline several major concerns that necessitate a substantial revision of the manuscript. Abstract: • Line 21: The acronym “MHR” is used here, while “HRmax” appears elsewhere. Please ensure consistency in terminology throughout the text. • Line 37: In the abstract results section, p-values are reported. Given that p-values are highly dependent on sample size, it is recommended to also report effect sizes along with their confidence intervals. Main Text: • Line 134: It is essential to report the age distribution of the sample. A graphical representation (e.g., kernel density plot) would clarify whether the sample is approximately uniform or biased. • Line 137: Sample size is a critical aspect of this type of research. In comparison to the studies cited in the introduction, the sample here appears underpowered. A power analysis is necessary to justify the chosen sample size, specifying the primary outcome and the minimum detectable effect. • Line 142: Who were the participants? Why were they undergoing GXT testing? What population does this sample represent? These are crucial elements to support the study's external validity. • Line 169: A scatterplot with age on the x-axis and HRmax on the y-axis should be included, with the regression lines for the seven equations superimposed. • Line 182: Why was CRF treated as a binary variable? This dichotomization is not appropriate. All analyses involving CRF should be re-run treating it as a continuous covariate. Also, include a kernel density plot of CRF values, as well as a plot of CRF vs age, stratified by sex. • Line 189: A repeated-measures ANOVA should be conducted using CRF as a covariate, and post hoc tests should compare the regression coefficients (R, a, and b) appropriately. • Line 198: All analyses should be repeated using CRF as a continuous covariate. • Line 236: The dichotomization into “high” and “low” CRF groups is arbitrary and not physiologically grounded. Eliminate this split and instead stratify by sex. • The term “female” should be removed from the table where not necessary. • Cohen’s d values should be reported as absolute values. • Figure 1: Some predicted MHR values are unreasonably low and likely reflect data entry or estimation errors; these points should be removed. Since all prediction methods are linear equations, distributions should vary only by intercept and scale, not shape. This consistency is not reflected in the figure, indicating possible issues in its construction. While the topic of this study is undoubtedly relevant and the manuscript is generally well-written, the current version suffers from multiple critical issues that compromise its scientific validity: • The sample appears underpowered and lacks justification through a power analysis. • CRF is inappropriately treated as a categorical variable, introducing artificial thresholds and reducing statistical power. • Key descriptive data (e.g., age and CRF distributions) are missing. • Graphical representations are either lacking or flawed. • The statistical methods, particularly in regard to interaction effects and covariate inclusion, require complete re-evaluation. Given these major concerns, I do not believe the manuscript is ready for publication in its current form. However, with a thorough methodological revision, clearer data visualization, and a more nuanced statistical approach (especially using CRF as a continuous covariate), the manuscript could be resubmitted and reevaluated. Recommendation: Major Revision Reviewer #3: General comments: In general, the article is well written, and the authors have made an effort to be as precise as possible in respecting the guidelines (e.g., providing information about data access, etc.). However, the study requires improvements in certain aspects of writing and a better justification for the use of specific statistical approaches. Before delving deeper into the specific comments, it is recommended to revise (and add line numbers, as well as after Table 2) the manuscript based on the significant points outlined below. Title: As this is a retrospective study, it would be advisable to classify and describe it as exploratory. Including the word exploratory in the title could be helpful. Please refer to the recent article by Ditroilo and colleagues (PMID: 40197233) on the importance of exploratory research (see detailed comments below). Abstract: The abstract, in general, should be reformed once the changes are made in the main text. Introduction: While the Introduction is well written, it is slightly too long. It would be more effective if it were more concise and ideally no longer than 1.5 to 2 pages. Please reduce the content. Specific lines comments: Line 82: The sentence “Furthermore, sex can influence cardiovascular responses to exercise” feels out of context. Consider providing a better transition or justification. Lines 127–128: Avoid stating hypotheses, especially in retrospective studies where a priori hypothesis testing is not feasible and could lead to the so-called HARKing (see Mesquida et al., 2022; PMID: 36533197). Limit this section to stating the main objectives. Again, the article by Ditroilo et al. (PMID: 40197233) may help in distinguishing between exploratory and confirmatory research. Materials and methods: The number of the ethical approval should also be present in the main text. Statistics: Please specify how data distribution was assessed, and which tests were used for non-normally distributed data, if applicable. Regarding sample size: since this is a retrospective study, there may be no formal justification. If that is the case, it is still important to disclose this information. Please provide a justification for the use of a dichotomous classification of CRF (High vs. Low) based on the 50th percentile. Dichotomizing a continuous variable such as VO₂max may lead to the loss of important information. If possible, consider treating CRF as a continuous variable. On the contrary, if it is not possible for whatever reason, try to justify the decision. Specific lines comments: Lines 150–151: The sentence “After a brief warm-up, the treadmill protocol ramped intensity continuously via speed and/or grade increments every 1–2 minutes” is too vague. Please provide a more detailed description of the protocol. Lines 180-182: Please, see the comment above on the division between high and low fitness levels. Lines 209-212: It is not clear how the top and bottom were determined. In particular, a justification of the criteria for this decision should be made. Line 211: Use a subscript for VO₂max. Results: After Table 2, line numbers are missing. Please correct this. The choice of the 20th percentile at the top and the bottom remains unjustified and seems arbitrary. Discussion: Line numbers are missing, making it difficult to reference specific points. Please address this. In general, the discussion should be reframed within the context of exploratory research. For instance, hypotheses should be proposed for future confirmatory studies rather than being inferred from the current findings. Moreover, a part related to the presence of interindividual variability should be incorporated and discussed. • From the sentence “This suggests that although individuals with lower CRF may exhibit slightly smaller prediction errors...” to the end of the paragraph should be revised in light of the exploratory nature of the study. • Figure 3 should be moved from the discussion to the results section. • The sentence “Although there were no statistically significant differences in prediction accuracy between High and Low CRF individuals in the primary analysis, the descriptive analyses revealed that individuals with higher CRF may exhibit greater prediction error across most equations” is particularly important. It is commendable that non-significant results are reported and discussed as did in the present study! Is is also possible to push this aspect in your discussion. • The statement “Exercise professionals should consider additional methods, such as perceived exertion or heart rate monitoring over time with wearables” is valid and could be expanded. Consider referencing Teso et al. (2022; PMID: 34967799) and Ferri Marini et al. (2024; PMID: 38711624) for additional context on heart rate prescription limitations and the relationship between RPE and physiological measures. • The sentence “Specifically, rather than offering a single-point estimate (e.g., “Your MHR is 180 bpm”), professionals can provide prediction intervals (e.g., “Your MHR is likely between 175–185 bpm”) to aid their clients’ understanding of the errors associated with MHR estimation.” sounds colloquial, it can be reformed in a more scientific way. • The sentence “Alternatively, when precision is critical, such as in clinical exercise testing or high-performance athletics, direct MHR measurement via graded exercise testing remains the gold standard” is debatable. In high-performance settings, maximal testing may not be feasible due to potential training disruption. Consider revising or removing this statement. Conclusion: It is important to state in the conclusion that all the findings of the present study should be confirmed in future confirmatory studies. Figures: Please, check all the figure titles and labels. For instance, Figure 2 (a, b, c, etc.) contains a spelling error in the left panel (i.e., Cardorespiratory fitness instead of Cardiorespiratory). Still, in the figures, although they appear clear and sharp when downloaded, they are somewhat blurred in the PDF file. Verify that they are meeting the minimum quality requirements and, if necessary, adjust them accordingly. Data availability: Even if the data are uploaded correctly to OSF, it is still necessary to cite them in the main text. Furthermore, it is probably better to anonymize the data. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Martin, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Reviewer #3 asked for some additional minor changes that could help to strengthen the manuscript further. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 20 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Stefano Amatori, Ph.D. Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #3: Yes ********** Reviewer #1: The authors have addressed all comments. No further changes are needed. The submission is ready to be accepted for publication Reviewer #3: General comments: Overall, the authors have made a commendable effort to improve the manuscript, implementing appropriate modifications where necessary. Below are some specific comments that may help further enhance the quality and readability of the work. Specific comments: Line 65. The sentence “which can be impractical and/or risky for many” can be improved and given in a more scientific language. Line 82. The sentence “sex can also influence cardiovascular responses to exercise”, while can be generally understood, contains a fundamental pitfall. Indeed, it is common for researchers to refer to sex as something that can influence responses to exercise, but this interpretation seems to suggest a reverse causality. This sentence should be then rephrased giving something like sexes can respond differently to exercise. Line 106. It could be avoided to define age as a “dominant predictor” if considering that usually the predictor is defined as something that shows whether something is likely to happen. Lines 137-139. The sample size part is now well explained, the recommendation here is also to cite the article from Lakens (https://doi.org/10.1525/collabra.33267) on the sample size justification and adapt the sentence consequently. Lines 195-196. For this procedure does not seem an arbitrary decision, please provide a citation here. Line 218. There is one more space after “interaction”, please remove it and check all over the text if this happened again. GXT testing protocol. Then, all the participants experienced (about) the same starting speed and the same increments? If this is the case, was the time to task failure between 8 and 12 for every participant? Moreover, how running in a 10% slope could have influenced the responses to exercise? Being a not common way of running it could be expected that people were not able to reach their maximum effort because of leg pain or other peripheral discomfort. The impact should be at least acknowledged. Table 1. This table can be improved visually. Indeed, it is advisable not to use all the borders but just the one at the top (i.e., below headings) and one at the bottom (i.e., between the last row and the notes). Additionally, it is suggested to use males and females instead of men and women, both in this table and all over the text. Table 2 is formatted as suggested for Table 1. It is advisable to be consistent across all the tables and adjust also Table 3 etc. Lines 412-413. Please, use males and females instead of men and women. Discussion. While the range of age is quite wide in the present study, there is no mention of it as a possible limitation. It should be included, at least discussed as the age ranges also outside the usual definition of adults (e.g., also people above 65 yrs old). How could it have an impact on the results? Line 425. Please, modify men and women also in the discussion. Line 444. The sentence “may exhibit more stereotypical physiological responses to maximal exertion” should be improved and explained more to allow the reader to understand the meaning of this paragraph. Lines 493-495. These lines are correct and explain a good point. The only suggestion here could be to explain just in a few more lines why HR has limitations (i.e., the presence of a cardiovascular drift). Lines 495-497. In this line there is a great point. For instance, regarding safety, there always should be awareness on the fact that in certain situations where HR cannot be used or can be a misleading parameter (e.g., patients under beta-blockers medications) require attention to different parameters for training monitoring. To be general, you can also expand this section using references of papers that tried to prescribe and monitor aerobic exercise intensity in treadmill running using different approaches and parameters, such as the papers in both general and clinical populations from Faricier et al (PMID: 38980336 and PMID: 39999365) and the papers from Nuuttila et al (PMID: 38956784 and PMID: 35975912). These references and topics could add great value to this piece of discussion. Lines 515-516. The sentence “As such, the study may be underpowered to detect small effects.” is just partially correct. Indeed, medium effects can be difficult to get with an underpowered design. Furthermore, underpowered design can also lead to an increase of the proportion of false positives in a literature where publication bias is present. It is advisable to include both in the text. For a reference on that, please check the article from Mesquida et al. (PMID: 36533197), in particular in section 2.2.2 of the paper (i.e., “Consequences of underpowered designs”). Lines 531-532. The sentence “who may systematically deviate from general trends.” Should be expanded in the view of making readers understand what is meant. Lines 536-538. The sentence “The results illustrate both the utility and the limitations of age-based MHR equations—useful for population-level estimates, yet insufficiently precise for individualized programming.” is to some extent counterintuitive. Indeed, it should be better explained why something could show both utility and limitations. Probably this sentence is more suitable for a discussion section, instead of a conclusion. Figures. Please, as already asked for in the text, make sure that in all figures men and women are changed with males and females. Figures 5 A, B, C, D, E, F, G. Please, try to avoid that the mean bias is overlapped with the plot dots. OSF raw data file. Please, consider modifying the column name which refers to gender. Indeed, it should not be confused with sex, which is more related to what has been made in the present article (i.e., it was considered as a biological factor). ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Exploratory Analysis of the Accuracy of Age-Based Maximal Heart Rate Equations Across Cardiorespiratory Fitness Levels PONE-D-25-30112R2 Dear Dr. Martin, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Stefano Amatori, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-30112R2 PLOS ONE Dear Dr. Martin, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Stefano Amatori Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .